AusPAR: Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat

Australian Public Assessment Report

AusPAR

AusPAR: Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat [PDF, 1.54 MB]

AusPAR: Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat [Word, 2.65 MB]

Attachment: Product Information: Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat [PDF, 278.83 KB]

Attachment: Product Information: Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat [Word, 297.5 KB]

Attachment: Extract from Clinical Evaluation Report: Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat [PDF, 1.61 MB]

Attachment: Extract from Clinical Evaluation Report: Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat [Word, 1.59 MB]

Device/Product Name

Stribild

Active ingredients

Tenofovir disoproxil fumarate / Emtricitabine / Elvitegravir / Cobicistat

AusPAR Date

5 August 2013

Published

11 October 2013

Submission Number

PM-2011-03533-3-2

Submission Type

New fixed dose combination

Decision

Approved